Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome.

Abstract

HBsAg-negative/HBcAb-positive haematopoietic stem cell transplant (HSCT) recipients are at high risk of hepatitis B virus (HBV) reactivation. Allogeneic HSCT recipients from years 2000 to 2010 were evaluated in order to study the impact of being HBsAg-negative/HBcAb-positive in this population. Overall, 137 of 764 patients (18%) were HBsAg-negative/HBcAb… (More)
DOI: 10.1111/1469-0691.12611

Topics

Cite this paper

@article{Mikulska2014HepatitisBR, title={Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome.}, author={Maria Mikulska and Laura Ambra Nicolini and Alessio Signori and Giovanna Rivoli and Valerio del Bono and A. M. Raiola and Carmen di Grazia and Alida Dominietto and Riccardo Varaldo and Anna Ghiso and Alamalina Bacigalupo and Catherine J Viscoli}, journal={Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases}, year={2014}, volume={20 10}, pages={O694-701} }